ORAL ONCOLOGY is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of oncology with a specific focus on oral diseases and cancers. Since its inception in 1996, this esteemed journal has provided a platform for high-quality research that addresses critical issues in oral surgery, cancer research, and related disciplines. With impressive rankings in Q1 in Oncology and Q1 in Oral Surgery, and recognized as Rank #1 in Dentistry and Oral Surgery by Scopus, ORAL ONCOLOGY consistently publishes impactful articles that contribute significantly to our understanding of oral cancers. The journal is committed to sharing pioneering findings that enhance clinical practices and improve patient outcomes. As a non-open access journal, it provides readers with exclusive access to cutting-edge research, ensuring that professionals, researchers, and students are at the forefront of developments in the field. Situated in the United Kingdom, ORAL ONCOLOGY serves as an indispensable resource for those dedicated to advancing oral health and oncology research through rigorous scientific inquiry and collaboration.

LARYNGOSCOPE, published by Wiley, is a premier journal in the field of Otorhinolaryngology, boasting an impressive impact factor and ranked #8 out of 123 in its category, placing it in the 93rd percentile among its peers. Since its inception in 1896, the journal has served as a vital platform for disseminating high-quality research, innovative clinical practices, and advancements in the study of ear, nose, and throat diseases. The journal is committed to providing comprehensive coverage of original research, case studies, and reviews that shape the future of Otorhinolaryngology. With a notable Q1 category ranking in 2023, it remains at the forefront of medical publications, making it an essential resource for researchers, health professionals, and students who seek to stay abreast of the latest developments in the field. Although not an Open Access journal, it provides valuable insights that contribute to the understanding and treatment of complex disorders within otolaryngology. The journal’s dedication to excellence ensures its readers receive cutting-edge information that is critical for advancing their work and enhancing patient care.

Annals of Diagnostic Pathology, published by Elsevier Science Inc, is a pivotal journal in the field of diagnostic pathology that has significantly contributed to the advancement of medical science since its inception in 1997. With an ISSN of 1092-9134 and E-ISSN of 1532-8198, this esteemed journal is positioned within the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, reflecting its high-quality research contributions, showcased by its ranking at #73 out of 208 in Scopus for the latter category. The journal's scope encompasses various aspects of diagnostic pathology, from innovative techniques to critical reviews of pathologic findings, making it an essential resource for researchers, medical professionals, and students dedicated to enhancing diagnostic accuracy and patient care. Although it does not currently offer open access options, its wide readership and impactful publications continue to influence clinical practices and research agendas. With a convergence period extending to 2024, Annals of Diagnostic Pathology remains a leading platform for disseminating valuable knowledge in this dynamic field.

Head & Face Medicine, published by BMC, serves as a vital open-access platform for advancing research and clinical practices in the fields of Dentistry, Otorhinolaryngology, and Neurology. Since its inception in 2005, this journal has nurtured contributions that span a diverse range of topics, making significant strides in understanding complex head and facial conditions. With an impressive categorization in the 2023 Journal Rankings, where it is recognized in Q1 for both Dentistry and Otorhinolaryngology, as well as Q2 for Neurology, it holds a prestigious position in the academic community, fostering innovative ideas and collaborations. The journal's commitment to free access ensures widespread availability of groundbreaking research, promoting knowledge dissemination among researchers, healthcare professionals, and students alike. Located in the United Kingdom and continuously prioritizing rigorous peer review, Head & Face Medicine is essential for anyone seeking to stay at the forefront of medical advancements concerning head and facial health.

ACTA OTO-LARYNGOLOGICA is a prestigious academic journal focusing on the field of otorhinolaryngology, published by Taylor & Francis Ltd in the United Kingdom. With an ISSN of 0001-6489 and E-ISSN 1651-2251, this journal has been a cornerstone in the dissemination of research in otolaryngology since its inception in 1918. It maintains a solid impact factor in the scholarly community, categorized in 2023 as Q3 in Medicine (miscellaneous) and Q2 specifically in Otorhinolaryngology, indicating its significance and quality of published work. Researchers and practitioners benefit from comprehensive articles that offer insights and advancements in clinical practices, surgical techniques, and emerging trends in the field. Though it follows a subscription model, ACTA OTO-LARYNGOLOGICA strives to remain accessible for professionals seeking the latest research findings that can enhance patient care and clinical decision-making. By fostering a platform for quality scholarship, the journal plays an essential role in advancing the science and practice of otorhinolaryngology, making it invaluable for researchers, medical professionals, and students alike.

Ocular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.

Oral & Maxillofacial Pathology Journal is a prominent peer-reviewed publication dedicated to advancing the field of oral and maxillofacial pathology. Published by the KAIRALI SOCIETY OF ORAL & MAXILLOFACIAL PATHOLOGISTS, this journal aims to provide a platform for sharing innovative research, clinical practices, and new techniques related to the diagnosis and management of oral diseases. With a commitment to open access, it ensures that valuable knowledge reaches a global audience of researchers, dental professionals, and students alike. Although specific impact metrics such as the HIndex and Scopus ranking are not listed, the journal is regarded as an essential resource for those involved in the oral health community. It plays a crucial role in fostering collaboration and disseminating cutting-edge advancements that can enhance patient care and clinical outcomes in oral pathology. For professionals looking to stay ahead in this dynamic field, Oral & Maxillofacial Pathology Journal serves as an indispensable tool for both foundational learning and advanced research.

Egyptian Journal of Otolaryngology (EJOT) is a premier open access journal dedicated to advancing the field of otorhinolaryngology. Published by Springer, the journal has been an essential resource for researchers and practitioners since its transition to open access in 2012. With an ISSN of 1012-5574 and E-ISSN 2090-8539, EJOT aims to facilitate the dissemination of high-quality research, covering a broad spectrum of topics within otolaryngology. The journal's significance is underscored by its current ranking in the Q3 category of the Scopus Otorhinolaryngology category, and it is positioned in the 23rd percentile of its field, reflecting its commitment to scholarly excellence. Researchers, professionals, and students alike will find valuable insights and innovative studies in the journal's articles, contributing to ongoing education and the advancement of best practices in ear, nose, and throat medicine. The journal is based in Germany with its operations centered at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, UNITED STATES, ensuring a global reach in the academic community.

CLINICAL NEUROPATHOLOGY is a vital scholarly journal published by DUSTRI-VERLAG DR KARL FEISTLE, specializing in the domains of neurology, pathology, and their clinical applications. Established in 1982 and spanning through to its projected completion in 2024, this journal disseminates high-quality research that significantly contributes to the understanding of neurological disorders and their pathological underpinnings. While the journal currently operates under a traditional access model, its commitment to rigorous peer review ensures the publication of impactful findings, strengthening its foothold in the field, as evidenced by its Q3 quartile rankings in several categories, including Medicine (miscellaneous), Neurology, and Pathology and Forensic Medicine. Those engaged in clinical research and practice will find CLINICAL NEUROPATHOLOGY to be an essential resource for the latest advancements, trends, and discussions that shape the future of neurological pathology.

Virchows Archiv, published by Springer, is an esteemed journal dedicated to the fields of Medicine and Pathology, featuring high-quality research from various domains including Cell Biology and Molecular Biology. With its inception dating back to 1947, Virchows Archiv has been a pivotal platform for advancing the understanding of pathological and forensic medicine. As evidenced by its impressive Scopus rank, placing it within the top 15% of journals in Pathology and Forensic Medicine, it continues to maintain a strong presence with a Q1 classification in its category as of 2023. Although it does not offer Open Access options, the journal remains critical for researchers and professionals seeking to publish and access pioneering findings that can impact clinical practices and the academic community. The journal’s rigorous peer-review process ensures that only the highest quality research is disseminated, making it an essential resource for those engaged in the ever-evolving fields of health and biological sciences.